New immune drug FL115 takes on Hard-to-Treat cancers
Disease control
Ongoing
This early-stage trial tests FL115, a protein designed to boost the body's immune cells to fight cancer. It involves 30 adults with advanced solid tumors that no longer respond to standard treatments. The main goals are to check safety, find the right dose, and see if the drug ca…
Phase: PHASE1 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC